Insider Transactions in Q4 2019 at Eli Lilly & CO (LLY)
Insider Transaction List (Q4 2019)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 20
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
19,705
-0.02%
|
$2,601,060
$132.9 P/Share
|
Dec 18
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
220,000
-0.1%
|
$28,380,000
$129.14 P/Share
|
Dec 17
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
215,000
-0.06%
|
$26,875,000
$125.82 P/Share
|
Dec 16
2019
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
89
+0.19%
|
$10,858
$122.85 P/Share
|
Dec 16
2019
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
111
+0.99%
|
$13,542
$122.85 P/Share
|
Dec 16
2019
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+0.03%
|
$2,074
$122.85 P/Share
|
Dec 16
2019
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
81
+2.7%
|
$9,882
$122.85 P/Share
|
Dec 09
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
10,962
-0.01%
|
$1,304,478
$119.7 P/Share
|
Dec 06
2019
|
Myles O'Neill SVP & Pres., Mfg. Operations |
SELL
Open market or private sale
|
Indirect |
25,000
-42.8%
|
$3,000,000
$120.0 P/Share
|
Dec 06
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
194,038
-0.08%
|
$23,284,560
$120.42 P/Share
|
Dec 06
2019
|
Alfonso G Zulueta SVP & President, Lilly Int'l |
SELL
Open market or private sale
|
Direct |
4,500
-13.31%
|
$540,000
$120.0 P/Share
|
Dec 04
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
210,000
-0.18%
|
$24,780,000
$118.52 P/Share
|
Nov 27
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
48,953
-0.04%
|
$5,727,501
$117.51 P/Share
|
Nov 26
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
56,729
-0.05%
|
$6,637,293
$117.81 P/Share
|
Nov 25
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
109,318
-0.09%
|
$12,790,206
$117.6 P/Share
|
Nov 22
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
251,736
-0.11%
|
$29,201,376
$116.02 P/Share
|
Nov 21
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
108,264
-0.09%
|
$12,450,360
$115.14 P/Share
|
Nov 19
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
205,000
-0.09%
|
$23,575,000
$115.36 P/Share
|
Nov 18
2019
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,552
+2.61%
|
$176,928
$114.07 P/Share
|
Nov 18
2019
|
Kathi P Seifert Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+2.02%
|
$174,876
$114.07 P/Share
|
Nov 18
2019
|
Marschall S Runge Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+10.72%
|
$174,876
$114.07 P/Share
|
Nov 18
2019
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,653
+13.07%
|
$188,442
$114.07 P/Share
|
Nov 18
2019
|
Jamere Jackson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+21.42%
|
$174,876
$114.07 P/Share
|
Nov 18
2019
|
William G Kaelin Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+8.22%
|
$179,478
$117.07 P/Share
|
Nov 18
2019
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+2.33%
|
$174,876
$114.07 P/Share
|
Nov 18
2019
|
Michael L Eskew Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+3.56%
|
$174,876
$114.07 P/Share
|
Nov 18
2019
|
Carolyn R Bertozzi Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+23.82%
|
$174,876
$114.07 P/Share
|
Nov 18
2019
|
Katherine Baicker Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,534
+7.59%
|
$174,876
$114.07 P/Share
|
Nov 18
2019
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,630
+3.38%
|
$185,820
$114.07 P/Share
|
Nov 18
2019
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,687
+37.31%
|
$192,318
$114.07 P/Share
|
Nov 18
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
10,598
-0.01%
|
$1,208,172
$114.0 P/Share
|
Nov 12
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
7,981
-0.01%
|
$909,834
$114.0 P/Share
|
Nov 11
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
100
-0.0%
|
$11,400
$114.06 P/Share
|
Nov 07
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
400
-0.0%
|
$45,600
$114.37 P/Share
|
Nov 06
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
173,918
-0.15%
|
$19,826,652
$114.05 P/Share
|
Nov 04
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
7,003
-0.01%
|
$798,342
$114.04 P/Share
|
Oct 31
2019
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
190,000
-0.08%
|
$21,660,000
$114.26 P/Share
|
Oct 30
2019
|
Myles O'Neill SVP & Pres., Mfg. Operations |
SELL
Bona fide gift
|
Direct |
222
-0.55%
|
-
|
Oct 25
2019
|
Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm |
BUY
Open market or private purchase
|
Direct |
5,000
+6.19%
|
$540,000
$108.61 P/Share
|
Oct 25
2019
|
Joshua L Smiley |
BUY
Open market or private purchase
|
Direct |
929
+2.86%
|
$99,403
$107.59 P/Share
|
Oct 25
2019
|
Anne E. White EVP & Pres, Lilly Neuroscience |
BUY
Open market or private purchase
|
Direct |
1,000
+4.34%
|
$108,000
$108.84 P/Share
|
Oct 25
2019
|
David A Ricks President, Chair, and CEO |
BUY
Open market or private purchase
|
Direct |
4,615
+2.85%
|
$498,420
$108.38 P/Share
|
Oct 24
2019
|
Michael J Harrington Senior VP and General Counsel |
SELL
Bona fide gift
|
Indirect |
3,000
-4.8%
|
-
|
Oct 24
2019
|
Jackson P Tai Director |
BUY
Open market or private purchase
|
Direct |
1,861
+3.19%
|
$199,127
$107.49 P/Share
|
Oct 21
2019
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
115
+8.95%
|
$12,305
$107.91 P/Share
|
Oct 21
2019
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+0.03%
|
$1,926
$107.91 P/Share
|
Oct 21
2019
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
126
+1.33%
|
$13,482
$107.91 P/Share
|
Oct 21
2019
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
101
+0.22%
|
$10,807
$107.91 P/Share
|